Metraipolis › archive › dc_5cbc6bd4dd50

Efficacy and safety of antibody-drug conjugate based therapy in locally advanced or metastatic urothelial carcinoma: a systematic review and network… — Europe PMC PMID:41953009

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41953009
DOI
10.3389/fimmu.2026.1728521
License (as archived)
solo-consultazione
Archived
2026-11-04T00:16:18.021Z
SHA-256 of the archived text
bf96895603bdbad8360a1cd129e09a9661cff9c287357f2b7a11e1f36db491cf
Stable URL of this page
https://metraipolis.com/documento/dc_5cbc6bd4dd50

How to cite

Efficacy and safety of antibody-drug conjugate based therapy in locally advanced or metastatic urothelial carcinoma: a systematic review and network… — Europe PMC PMID:41953009 — Europe PMC (en), https://europepmc.org/article/MED/41953009 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5cbc6bd4dd50 (Metraipolis archive dc_5cbc6bd4dd50, sha256 bf96895603bdbad8360a1cd129e09a9661cff9c287357f2b7a11e1f36db491cf)
BibTeX
@misc{dc5cbc6bd4dd50,
  title = {Efficacy and safety of antibody-drug conjugate based therapy in locally advanced or metastatic urothelial carcinoma: a systematic review and network… — Europe PMC PMID:41953009},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41953009},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5cbc6bd4dd50; sha256 bf96895603bdbad8360a1cd129e09a9661cff9c287357f2b7a11e1f36db491cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41953009. Agents can read the archived copy with the MCP tool read_document.